{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:50:19Z","timestamp":1762271419615,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,3,6]],"date-time":"2010-03-06T00:00:00Z","timestamp":1267833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00417-009-1289-x","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T11:22:00Z","timestamp":1267788120000},"page":"985-990","source":"Crossref","is-referenced-by-count":28,"title":["IL-2 and IFN-gamma in the retina of diabetic rats"],"prefix":"10.1007","volume":"248","author":[{"given":"Siv","family":"Johnsen-Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Sancho-Tello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Arnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Navea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Bosch-Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Javier Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,6]]},"reference":[{"key":"1289_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.20222","volume":"69","author":"J Chu","year":"2008","unstructured":"Chu J, Ali Y (2008) Diabetic retinopathy: a review. Drug Development Research 69:1\u201314","journal-title":"Drug Development Research"},{"key":"1289_CR2","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1155\/2007\/95103","volume":"2007","author":"TS Kern","year":"2007","unstructured":"Kern TS (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007:95103","journal-title":"Exp Diabetes Res"},{"key":"1289_CR3","first-page":"81","volume":"139","author":"S Schroder","year":"1991","unstructured":"Schroder S, Palinski W, Schmid-Schonbein GW (1991) Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 139:81\u2013100","journal-title":"Am J Pathol"},{"key":"1289_CR4","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","volume":"96","author":"K Miyamoto","year":"1999","unstructured":"Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 96:10836\u201310841","journal-title":"Proc Natl Acad Sci USA"},{"key":"1289_CR5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2337\/diabetes.50.6.1432","volume":"50","author":"D Boeri","year":"2001","unstructured":"Boeri D, Maiello M, Lorenzi M (2001) Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 50:1432\u20131439","journal-title":"Diabetes"},{"key":"1289_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1096\/fj.01-0707fje","volume":"16","author":"AM Joussen","year":"2002","unstructured":"Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. Faseb J 16:438\u2013440","journal-title":"Faseb J"},{"key":"1289_CR7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjo.2003.038133","volume":"88","author":"RA Kowluru","year":"2004","unstructured":"Kowluru RA, Odenbach S (2004) Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88:1343\u20131347","journal-title":"Br J Ophthalmol"},{"key":"1289_CR8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/db06-0427","volume":"56","author":"JA Vincent","year":"2007","unstructured":"Vincent JA, Mohr S (2007) Inhibition of caspase-1\/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 56:224\u2013230","journal-title":"Diabetes"},{"key":"1289_CR9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0002-9394(14)74052-8","volume":"114","author":"AM Abu el Asrar","year":"1992","unstructured":"Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT (1992) Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol 114:731\u2013736","journal-title":"Am J Ophthalmol"},{"key":"1289_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000267287","volume":"25","author":"S Tang","year":"1993","unstructured":"Tang S, Scheiffarth OF, Thurau SR, Wildner G (1993) Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmic Res 25:177\u2013185","journal-title":"Ophthalmic Res"},{"key":"1289_CR11","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1167\/iovs.04-1057","volume":"46","author":"AD Meleth","year":"2005","unstructured":"Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL 3rd, Chew EY (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46:4295\u20134301","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1289_CR12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.exer.2005.10.002","volume":"82","author":"JI Patel","year":"2006","unstructured":"Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA (2006) Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Exp Eye Res 82:798\u2013806","journal-title":"Exp Eye Res"},{"key":"1289_CR13","first-page":"637","volume":"14","author":"R Maier","year":"2008","unstructured":"Maier R, Weger M, Haller-Schober EM, El-Shabrawi Y, Wedrich A, Theisl A, Aigner R, Barth A, Haas A (2008) Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Mol Vis 14:637\u2013643","journal-title":"Mol Vis"},{"key":"1289_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/IAE.0b013e31816576d5","volume":"28","author":"P Murugeswari","year":"2008","unstructured":"Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V (2008) Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales\u2019 disease. Retina 28:817\u2013824","journal-title":"Retina"},{"key":"1289_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00592-008-0054-7","volume":"46","author":"SK Vijay","year":"2009","unstructured":"Vijay SK, Mishra M, Kumar H, Tripathi K (2009) Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes. Acta Diabetol 46:27\u201333","journal-title":"Acta Diabetol"},{"key":"1289_CR16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0891-5849(98)00184-1","volume":"25","author":"JC Steege ter","year":"1998","unstructured":"ter Steege JC, Koster-Kamphuis L, van Straaten EA, Forget PP, Buurman WA (1998) Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med 25:953\u2013963","journal-title":"Free Radic Biol Med"},{"key":"1289_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/IR:22:1:1","volume":"22","author":"VK Singh","year":"2000","unstructured":"Singh VK, Mehrotra S, Narayan P, Pandey CM, Agarwal SS (2000) Modulation of autoimmune diseases by nitric oxide. Immunol Res 22:1\u201319","journal-title":"Immunol Res"},{"key":"1289_CR18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/IAE.0b013e31815ec32d","volume":"28","author":"C Gustavsson","year":"2008","unstructured":"Gustavsson C, Agardh CD, Hagert P, Agardh E (2008) Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. Retina 28:645\u2013652","journal-title":"Retina"},{"key":"1289_CR19","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1167\/iovs.07-0273","volume":"49","author":"A Nehme","year":"2008","unstructured":"Nehme A, Edelman J (2008) Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. Invest Ophthalmol Vis Sci 49:2030\u20132038","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1289_CR20","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1167\/iovs.04-0633","volume":"45","author":"RA Kowluru","year":"2004","unstructured":"Kowluru RA, Odenbach S (2004) Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci 45:4161\u20134166","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1289_CR21","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","volume":"54","author":"JK Krady","year":"2005","unstructured":"Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559\u20131565","journal-title":"Diabetes"},{"key":"1289_CR22","first-page":"RA179","volume":"14","author":"K Olejniczak","year":"2008","unstructured":"Olejniczak K, Kasprzak A (2008) Biological properties of interleukin 2 and its role in pathogenesis of selected diseases\u2014a review. Med Sci Monit 14:RA179\u2013RA189","journal-title":"Med Sci Monit"},{"key":"1289_CR23","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.4049\/jimmunol.176.9.5255","volume":"176","author":"PA Antony","year":"2006","unstructured":"Antony PA, Paulos CM, Ahmadzadeh M, Akpinarli A, Palmer DC, Sato N, Kaiser A, Hinrichs CS, Klebanoff CA, Tagaya Y, Restifo NP (2006) Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol 176:5255\u20135266","journal-title":"J Immunol"},{"key":"1289_CR24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/10428199909145740","volume":"35","author":"A Dmoszynska","year":"1999","unstructured":"Dmoszynska A, Kandefer-Szerszen M, Rolinski J, Legiec W, Kaminska T (1999) Influence of low dose rIL-2 treatment on endogenous cytokine production, expression of surface IL-2R and the level of soluble IL-2R in patients with minimal residual disease. Leuk Lymphoma 35:355\u2013366","journal-title":"Leuk Lymphoma"},{"key":"1289_CR25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2741\/1631","volume":"10","author":"DJ Kuhn","year":"2005","unstructured":"Kuhn DJ, Dou QP (2005) The role of interleukin-2 receptor alpha in cancer. Front Biosci 10:1462\u20131474","journal-title":"Front Biosci"},{"key":"1289_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13547500601066410","volume":"12","author":"E Bien","year":"2007","unstructured":"Bien E, Balcerska A, Kuchta G (2007) Serum level of soluble interleukin-2 receptor alpha correlates with the clinical course and activity of Wilms\u2019 tumour and soft tissue sarcomas in children. Biomarkers 12:203\u2013213","journal-title":"Biomarkers"},{"key":"1289_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj\/eye\/6700095","volume":"16","author":"S Doganay","year":"2002","unstructured":"Doganay S, Evereklioglu C, Er H, Turkoz Y, Sevinc A, Mehmet N, Savli H (2002) Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16:163\u2013170","journal-title":"Eye"},{"key":"1289_CR28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2249.2004.02470.x","volume":"136","author":"E Matteucci","year":"2004","unstructured":"Matteucci E, Malvaldi G, Fagnani F, Evangelista I, Giampietro O (2004) Redox status and immune function in type I diabetes families. Clin Exp Immunol 136:549\u2013554","journal-title":"Clin Exp Immunol"},{"key":"1289_CR29","first-page":"2667","volume":"35","author":"K Geiger","year":"1994","unstructured":"Geiger K, Howes E, Gallina M, Huang XJ, Travis GH, Sarvetnick N (1994) Transgenic mice expressing IFN-gamma in the retina develop inflammation of the eye and photoreceptor loss. Invest Ophthalmol Vis Sci 35:2667\u20132681","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1289_CR30","first-page":"27","volume":"80","author":"M Miranda","year":"2006","unstructured":"Miranda M, Muriach M, Rom\u00e1 J, Bosch-Morell F, Genov\u00e9s JM, Barcia J, Araiz J, Diaz-Llopis M, Romero FJ (2006) Oxidative stress in a model of experimental diabetic retinopathy. II. Peroxynitrite scavengers utility. Arch Soc Esp Oftalmol 80:27\u201332","journal-title":"Arch Soc Esp Oftalmol"},{"key":"1289_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.niox.2008.09.001","volume":"20","author":"Z Yuan","year":"2009","unstructured":"Yuan Z, Feng W, Hong J, Zheng Q, Shuai J, Ge Y (2009) p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose. Nitric Oxide 20:9\u201315","journal-title":"Nitric Oxide"},{"key":"1289_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1023223614407","volume":"18","author":"F Gesbert","year":"1998","unstructured":"Gesbert F, Delespine-Carmagnat M, Bertoglio J (1998) Recent advances in the understanding of interleukin-2 signal transduction. J Clin Immunol 18:307\u2013320","journal-title":"J Clin Immunol"},{"key":"1289_CR33","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.166.3.1723","volume":"166","author":"A Martino","year":"2001","unstructured":"Martino A, JHt H, Lord JD, Moon JJ, Nelson BH (2001) Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J Immunol 166:1723\u20131729","journal-title":"J Immunol"},{"key":"1289_CR34","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1074\/jbc.M308998200","volume":"279","author":"JJ Moon","year":"2004","unstructured":"Moon JJ, Rubio ED, Martino A, Krumm A, Nelson BH (2004) A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J Biol Chem 279:5520\u20135527","journal-title":"J Biol Chem"},{"key":"1289_CR35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.micinf.2008.09.010","volume":"10","author":"MT Shio","year":"2008","unstructured":"Shio MT, Olivier M, Jancar S, Ribeiro-Dias F (2008) Crucial cytokine interactions in nitric oxide production induced by Mycoplasma arthritidis superantigen. Microbes Infect 10:1543\u20131551","journal-title":"Microbes Infect"},{"key":"1289_CR36","first-page":"3972","volume":"41","author":"TS Kern","year":"2000","unstructured":"Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41:3972\u20133978","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1289_CR37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/417182a","volume":"417","author":"R Hanayama","year":"2002","unstructured":"Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417:182\u2013187","journal-title":"Nature"},{"key":"1289_CR38","first-page":"120","volume":"9","author":"CA Ogden","year":"2006","unstructured":"Ogden CA, Elkon KB (2006) Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr Dir Autoimmun 9:120\u2013142","journal-title":"Curr Dir Autoimmun"},{"key":"1289_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tcb.2006.02.003","volume":"16","author":"Y Wu","year":"2006","unstructured":"Wu Y, Tibrewal N, Birge RB (2006) Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol 16:189\u2013197","journal-title":"Trends Cell Biol"},{"key":"1289_CR40","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.4049\/jimmunol.181.5.3277","volume":"181","author":"G Ren","year":"2008","unstructured":"Ren G, Su J, Zhao X, Zhang L, Zhang J, Roberts AI, Zhang H, Das G, Shi Y (2008) Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol 181:3277\u20133284","journal-title":"J Immunol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1289-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1289-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:13:57Z","timestamp":1739927637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1289-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,6]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1289-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2010,3,6]]}}}